Efficacy and safety of intra-operative thromboprophylaxis with low-molecular-weight-heparin or heparin in patients undergoing surgical resection of colorectal cancer: A post-hoc analysis of the PERIOP-01 trial.

Authors :: Wang TF
Mallick R
Noureldin A
Pecarskie A
Carrier M
Auer R
Source :: Thrombosis research [Thromb Res] 2024 Oct; Vol. 242, pp. 109123. Date of Electronic Publication: 2024 Aug 20.
Publication Year :: 2024
Abstract: Competing Interests: Declaration of competing interest M. Carrier has received research funding from BMS, Pfizer, and Leo Pharma, and honoraria from Bayer, Pfizer, BMS, Servier, and Leo Pharma. All other authors have no relevant conflicts of interest to disclose.

Subjects :: Humans
Female
Male
Aged
Middle Aged
Venous Thromboembolism prevention & control
Venous Thromboembolism etiology
Treatment Outcome
Colorectal Neoplasms surgery
Heparin, Low-Molecular-Weight therapeutic use
Anticoagulants therapeutic use
Heparin therapeutic use
Heparin adverse effects

Full Text Access

Tools